Navigation Links
synQUAD Technology

ProductssynQUAD Technology
Company Genomic Solutions
Item synQUAD Technology
Features Inquire
Description synQUAD technology is a patented non-contact dispensing technique that couples a high precision syringe with a microsolenoid valve and stage stepper motor. synQUAD dispenses a precise nanoliter volume of liquid onto various slides, plates, or membranes. At 100 nL dispense volume per well, coefficient of variation (CVs) are less than 10%. An 8-channel synQUAD system dispenses 100 nL into a standard 384 well microtiter plate, in less than 10 seconds. Each channel can be independently controlled for both volume and position. Although specific methods and analytical approaches vary, there are common processes for which synQUAD, an innovative low volume dispenser can be successfully integrated.
Info Genomic Solutions
Customer Service: (734) 975-4800
Web site: http://www.genomicsolutions.com/

Related medicine products :

1. StealthStation TRIA Surgical Navigation Technology
2. S660 with Discrete Technology Coronary Stent System
3. Sovereign with WhiteStar Cold Phaco Technology
4. Diamond Carpal Fusion Plates with System Pack Technology
5. StealthStation TREON plus Surgical Navigation Technology
6. S670 with Discrete Technology Over-the-Wire Coronary Stent System
7. S7 with Discrete Technology Coronary Stent System
8. BeStent2 With Discrete Technology
9. 3900/P Pulse Oximeter with TruTrak+ Technology
10. 3800 Pulse Oximeter with TruTrak+ Technology
11. Shandon Coverplate™ Technology
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
... a solid phase two-site enzyme immunoassay. ... technique in which two monoclonal antibodies are ... human insulin molecule. During incubation, insulin ... antibodies and anti-insulin antibodies bound to the ...
... hormone responsible for the control of glucose metabolism. ... the islets of Langerhans as the precursor, proinsulin, ... Both are secreted in equimolar amounts into ... is comprised of two polypeptide chains, the A-chain ...
... an integral part of the enzymatic cascade ... as well as the degradation of Bradykinin. ... is primarily located in endothelial cells. ACE ... for sarcoidosis and myocardial infarction but is ...
Medicine Products:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/29/2017)... MD (PRWEB) , ... April 29, 2017 , ... More ... jobs, so what are Americans doing in their leisure time that causes hearing loss? ... lifestyle habits that may be contributing to hearing loss, as well as schedule a ...
(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... Clara, CA (PRWEB) , ... April 28, 2017 ... ... is pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep ... user experience, since it streamlines the reporting process and provides a familiar interface ...
(Date:4/28/2017)... ... 2017 , ... Getting enough sleep affects much more than energy – it also has mental ... sleep can compromise motor reaction time, which can increase the risk of having a car ... following tips from the NSF to help you sleep better and feel better:, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive Pharmaceutical ... today announced positive preclinical results demonstrating anti-fibrotic ... for non-alcoholic steatohepatitis (NASH), in an additional ... NV556 has previously shown similar anti-fibrotic ... Today, NeuroVive,s scientists present novel data demonstrating ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: